Lion, M., Harlé, A., Salleron, J., Ramacci, C., Campone, M., & Merlin, J. (2016). Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer. Oncol Lett.
Citação norma ChicagoLion, Maëva, Alexandre Harlé, Julia Salleron, Carole Ramacci, Mario Campone, and Jean-Louis Merlin. "Trastuzumab As a Preoperative Monotherapy Does Not Inhibit HER2 Downstream Signaling in HER2-positive Breast Cancer." Oncol Lett 2016.
Citação norma MLALion, Maëva, et al. "Trastuzumab As a Preoperative Monotherapy Does Not Inhibit HER2 Downstream Signaling in HER2-positive Breast Cancer." Oncol Lett 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.